76 related articles for article (PubMed ID: 16395994)
1. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
Hung HM; Wang SJ; O'Neill R
Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
[TBL] [Abstract][Full Text] [Related]
2. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
[TBL] [Abstract][Full Text] [Related]
4. Some essential considerations in the design and conduct of non-inferiority trials.
Fleming TR; Odem-Davis K; Rothmann MD; Li Shen Y
Clin Trials; 2011 Aug; 8(4):432-9. PubMed ID: 21835862
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W
Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
[TBL] [Abstract][Full Text] [Related]
6. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.
Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
PLoS One; 2010 Oct; 5(10):e13550. PubMed ID: 21048948
[TBL] [Abstract][Full Text] [Related]
7. Non-inferiority clinical trials: Practical issues and current regulatory perspective.
Gupta SK
Indian J Pharmacol; 2011 Jul; 43(4):371-4. PubMed ID: 21844987
[TBL] [Abstract][Full Text] [Related]
8. The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial.
Quartagno M; Chan M; Turkova A; Ford D; White IR
Trials; 2023 Aug; 24(1):556. PubMed ID: 37626423
[TBL] [Abstract][Full Text] [Related]
9. Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study.
Mo Y; Lim C; Mukaka M; Cooper BS
Wellcome Open Res; 2019; 4():207. PubMed ID: 32420455
[TBL] [Abstract][Full Text] [Related]
10. Incomplete data analysis of non-inferiority clinical trials: Difference between binomial proportions case.
Sidi Y; Harel O
Contemp Clin Trials Commun; 2020 Jun; 18():100567. PubMed ID: 32426549
[TBL] [Abstract][Full Text] [Related]
11. [Non-inferiority trials].
Angeli F; Verdecchia P; Coiro S; Santucci A; Notaristefano F; Bartolini C; Reboldi G
G Ital Cardiol (Rome); 2024 Apr; 25(4):262-269. PubMed ID: 38526362
[TBL] [Abstract][Full Text] [Related]
12. Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trials.
Gladstone BP; Vach W
PLoS One; 2014; 9(7):e103616. PubMed ID: 25080093
[TBL] [Abstract][Full Text] [Related]
13. Meeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: the hybrid design.
Soon GG; Nie L; Hammerstrom T; Zeng W; Chu H
BMJ Open; 2011 Jan; 1(2):e000156. PubMed ID: 22021876
[TBL] [Abstract][Full Text] [Related]
14. Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.
Chowdhury S; Tiwari RC; Ghosh S
Stat Biopharm Res; 2019; 11(1):34-43. PubMed ID: 31602287
[TBL] [Abstract][Full Text] [Related]
15. Noninferiority trials.
Snapinn SM
Curr Control Trials Cardiovasc Med; 2000; 1(1):19-21. PubMed ID: 11714400
[TBL] [Abstract][Full Text] [Related]
16. Is Noninferior Not Inferior?
Kadire S; Hardin CC; Takvorian KS; Sacks CA
NEJM Evid; 2022 Jan; 1(1):EVIDstat2100040. PubMed ID: 38319215
[TBL] [Abstract][Full Text] [Related]
17. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
Tsong Y; Zhang JJ
Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
[TBL] [Abstract][Full Text] [Related]
18. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
19. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
20. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
Hung HM; Wang SJ; O'Neill R
Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
